Filing Details
- Accession Number:
- 0001127430-19-000083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-06-10 16:05:57
- Reporting Period:
- 2019-06-06
- Accepted Time:
- 2019-06-10 16:05:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1401017 | Nicole S Orlov Schaeffer | 10 Finderne Avenue Building 10 Bridgewater NJ 08807 | Chief People Strategy Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option | Acquisiton | 2019-06-06 | 12,000 | $6.96 | 36,350 | No | 4 | M | Direct | |
| Stock Option | Disposition | 2019-06-06 | 12,000 | $23.24 | 24,350 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-06-06 | 12,000 | $0.00 | 12,000 | $6.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,226 | 2023-01-02 | No | 4 | M | Direct |
Footnotes
- This is the weighted average sales price representing 12,000 shares sold at prices ranging from $23.00 to $23.66 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Stock options granted under the Company's 2000 Incentive Plan. These stock options are currently exercisable.
Billionaire Hedge Funds
